Credit & Asset Repac Stock Quote GRD - Stock Price, News, Charts, Message Board, Trades

Register for real-time alerts, custom portfolio, and market movers

Get Started

Home
Investing
Stocks
USA
NYSE
Public CR & Repackaged Secs (GRD) Quote

Public CR & Repackaged Secs (GRD)

0.00

0.00

(0.00%)

Closed July 30 4:00PM

Delayed by 15 minutes

0.00

0.00

( 0.00% )

Pre Market: -

Delayed by 15 minutes

Empower your portfolio: Real-time discussions and actionable trading ideas.

Current Price

-

Bid

-

Ask

-

Volume

-

0.00 Day's Range 0.00

0.00 52 Week Range 0.00

Previous Close

-

Open

-

Last Trade

Last Trade Time

-

Average Volume (3m)

-

Financial Volume

-

VWAP

-

FeaturedELEMENT79 GOLD CORP PROVIDES UPDATE ON CHACHAS COMMUNITY CHARTER AND REVENUE GENERATION, M&A ACTIVITIES

FeaturedCannabix Technologies to Deliver Innovative Breath Logix Alcohol Screening Device to Texas, USA

Enveric Biosciences Announces Preclinical Results Confirming Potential of EB-003 to be Dosed Orally

Confirmation of oral bioavailability and significant brain exposure in rodent models supports expedited development of EB-003, with Investigational New Drug (IND) filing and first patient dosed...

Aries Science & Technology and Enveric Biosciences Announce Licensing Agreement

Aries to clinically develop and market Enveric’s patented product for radiation dermatitis Enveric Biosciences (NASDAQ: ENVB) (“Enveric”), a biotechnology company dedicated to the development of...

Form 8-K - Current report

Enveric Biosciences Announces Patent Granted for Drug Candidate

US patent includes broad claims for treating brain neurological disorders Enveric Biosciences (NASDAQ: ENVB) (“Enveric” or the “Company”), a biotechnology company dedicated to the development of...

Form S-3 - Registration statement under Securities Act of 1933

Enveric Biosciences Provides Strategic Outlook and Pipeline Update, Elevating EB-003 to Lead Development Candidate

EB-003 is a novel, neuroplastogenic molecule designed to treat severe mental health disorders without the hallucinogenic effect typically associated with psychedelic-based compounds Enveric is...

Form 3 - Initial statement of beneficial ownership of securities

Enveric Biosciences to Participate in BIO International Convention 2024

Enveric Biosciences (NASDAQ: ENVB) (“Enveric” or the “Company”), a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
EOIEaton Vance Enhanced Equity Income Fund	$ 21.13 (12.10%)	36
SRFMSurf Air Mobility Inc	$ 0.344 (9.00%)	1
NMRNomura Holdings Inc	$ 6.30 (7.69%)	4.31k
HWMHowmet Aerospace Inc	$ 89.00 (7.42%)	9.4k
SWKStanley Black and Decker Inc	$ 103.32 (7.15%)	25.97k
AIUMeta Data Limited	$ 4.20 (-7.89%)	47.82k
FMSFresenius Medical Care AG	$ 18.90 (-7.17%)	13.61k
DEODiageo Plc	$ 122.24 (-7.09%)	41.64k
RYIRyerson Holding Corporation	$ 23.52 (-6.96%)	160
HIPOHippo Holdings Inc	$ 17.70 (-6.40%)	100
PFEPfizer Inc	$ 31.00 (0.91%)	1.21M
PGProcter and Gamble Co	$ 162.99 (-4.08%)	234.87k
NIONIO Inc	$ 4.34 (-1.14%)	192.26k
MRKMerck and Co Inc	$ 124.35 (-2.68%)	173.14k
XPEVXPeng Inc	$ 8.11 (-1.58%)	153.76k

glenn1919

glenn1919 3 minutes ago

TWOU.......TIVC........TRLY........................https://stockcharts.com/h-sc/ui?s=TWOU&p=D&yr=0&mn=2&dy=12&id=p84071410134
https://stockcharts.com/h-sc/ui?s=TIVC&p=D&yr=0&mn=2&dy=12&id=p84071410134
https://stockcharts.com/h-sc/ui?s=TLRY&p=D&yr=0&mn=2&dy=12&id=p84071410134

Menace212

Menace212 4 minutes ago

A cent at a time dawg otherwise u risk a anxiety/panic attack lol

Jack_Bolander

Jack_Bolander 4 minutes ago

A New COO - Why would anyone leave a hugely successful company like Amazon, and go to a struggling Mess in a one-horse backwater like PLUG ?

I am already questioning his decision-making abilities.

JJZander

JJZander 4 minutes ago

glenn1919

glenn1919 5 minutes ago

GOEV.................MULN..............................https://stockcharts.com/h-sc/ui?s=GOEV&p=D&yr=0&mn=2&dy=12&id=p84071410134
https://stockcharts.com/h-sc/ui?s=MULN&p=D&yr=0&mn=2&dy=12&id=p84071410134

ALDRADJKD123

ALDRADJKD123 5 minutes ago

They are suffering from Ostrich Syndrome. Most have no ideal what they are even protesting about.

TheFinalCD

TheFinalCD 5 minutes ago

https://x.com/READY_2_PROFIT/status/1818256964184404478

webprods

webprods 6 minutes ago

I din’t wanna predict 48 bucks for share to avoid somebody heart failure. Now I can continue smoke my joint. Good luck

Hosai

Hosai 7 minutes ago

" Still waiting for full PDD results, ALZ data published in a reputable, peer-reviewed science journal"

Dr Sabbagh himself is on the editorial board of some of the key journals so whilst not in a peer review journal yet the fact that he presented their data at the biggest alzhimers co

work-n-hard

work-n-hard 7 minutes ago

JNdouble1

JNdouble1 7 minutes ago

A lot of emotional investors here!

I get it, I used to be that way too.

It still surprises me to see so many, who otherwise present themselves as knowledgeable, resort to conspiracy theories and regulatory malfeasance arguments.

jackson73

jackson73 8 minutes ago

IMNN 4.20 there's the news...

https://www.globenewswire.com/news-release/2024/07/30/2920936/0/en/IMUNON-Announces-11-1-Month-Increase-in-Overall-Survival-in-Patients-with-Newly-Diagnosed-Advanced-Ovarian-Cancer-Treated-with-IMNN-001.html

Renegades17

Renegades17 8 minutes ago

I know next to nothing about BZWR, but have held some IPSI for a while. I wouldn't draw the conclusion that BZWR is exempt from filing the missing quarterlies. First, the 8-k for the merger hasn't been filed yet. It's quite likely, if the IPSI team is smart, that a condition requiring BZWR become

work-n-hard

work-n-hard 8 minutes ago

jedijazz

jedijazz 8 minutes ago

$NBIO NEWS! Nascent Biotech Presents at the July Emerging Growth Conference; Nascent CEO-Sean Carrick-Discusses Phase I Results and Forward Clinical Strategy while laying out Investment Opportunity of the Company https://finance.yahoo.com/news/nascent-biotech-presents-july-emerging-120000873.html?so

jedijazz

jedijazz 8 minutes ago

$NBIO NEWS! Nascent Biotech Presents at the July Emerging Growth Conference; Nascent CEO-Sean Carrick-Discusses Phase I Results and Forward Clinical Strategy while laying out Investment Opportunity of the Company https://finance.yahoo.com/news/nascent-biotech-presents-july-emerging-120000873.html?so

Monksdream

Monksdream 8 minutes ago

IMNN over $4 another lucrative Schwab session

urge2surge

urge2surge 8 minutes ago

The entire program has zero credibility, past and present. The missed opportunities, millions fleeced and time wasted, should give anyone pause on this shell. There's no way to verify any legitimacy at HQ and everything is highly suspect. He sold the goo, and everybody got the poo. Everything relate

tradernewstip

tradernewstip 8 minutes ago

$CBDW New Blog: #Transforming Industries: How AI Chatbots Can Drive Success for 1606 Corporation (CBDW) in Solar, Automotive, and Finance https://cbdw.ai/transforming-industries-how-ai-chatbots-can-drive-success-for-1606-corporation-cbdw-in-solar-automotive-and-finance/

webprods

webprods 9 minutes ago

If Royal family is really involved then they’re a huge rich whales and they not gonna waste the time to play pink company business. My prediction for HIRU is at list $ 9.50 per share at start and $ 22 when crowned investors will jump in. Of course if is $ 358 billions of Royal family involved.

PioneerCorsair42

PioneerCorsair42 9 minutes ago

Wot? Keep up with me if you can as I’m saying it WILL BE hitting 50 in the near future and not that it recently has.

You also implied it was easy when you used the RSI to male the call to sell when it was up.

You should take a nap this aft!

INFINITI

INFINITI 9 minutes ago

MartinLutherKing

MartinLutherKing 10 minutes ago

Today we live the dream FOXO

janice shell

janice shell 12 minutes ago

Attorney Mark Basile to Participate in Federal Enforcement Action SEC v. Carebourn Capital L.P. and Chip Alvin Rice

https://www.securitieslawyer101.com/2024/attorney-mark-basile-to-participate-in-federal-enforcement-action-sec-v-carebourn-capital-l-p-and-chip-alvin-rice/

Credit & Asset Repac

Delayed Upgrade Clock